Insider · CIK 0001878732

Samuel George A. III

Reports to the SEC for 1 company · CARLSBAD, CA

sec.gov

Transactions

Companies

Filings

CIK

0001878732

Forms 4 and 5

Insider transactions

22 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-03-05	LCTXLineage Cell Therapeutics, Inc. · Employee Stock Option (Right to Buy)A Award	General Counsel and Secretary	AAward	+900K sh	—	—	900,000
2026-02-11	LCTXLineage Cell Therapeutics, Inc.M Exercise/Conversion	General Counsel and Secretary	MExercise/Conversion	+6,075 sh	—	—	33,565
2026-02-11	LCTXLineage Cell Therapeutics, Inc.F Tax Payment	General Counsel and Secretary	FTax Payment	−2,502 sh	$1.80	−$4,503.6	31,063
2026-02-11	LCTXLineage Cell Therapeutics, Inc. · Restricted Stock UnitsM Exercise/Conversion	General Counsel and Secretary	MExercise/Conversion	−6,075 sh	—	—	0
2025-12-19	LCTXLineage Cell Therapeutics, Inc.A Award	General Counsel and Secretary	AAward	+1,735 sh	—	—	27,555
2025-12-19	LCTXLineage Cell Therapeutics, Inc.F Tax Payment	General Counsel and Secretary	FTax Payment	−65 sh	$1.68	−$109.2	27,490
2025-03-10	LCTXLineage Cell Therapeutics, Inc. · Employee Stock Option (Right to Buy)A Award	General Counsel and Secretary	AAward	+750K sh	—	—	750,000
2025-02-11	LCTXLineage Cell Therapeutics, Inc. · Restricted Stock UnitsM Exercise/Conversion	General Counsel and Secretary	MExercise/Conversion	−6,076 sh	—	—	6,075
2025-02-11	LCTXLineage Cell Therapeutics, Inc.M Exercise/Conversion	General Counsel and Secretary	MExercise/Conversion	+6,076 sh	—	—	28,260
2025-02-11	LCTXLineage Cell Therapeutics, Inc.F Tax Payment	General Counsel and Secretary	FTax Payment	−2,440 sh	$0.65	−$1,586	25,820
2024-11-26	LCTXLineage Cell Therapeutics, Inc.P Purchase	General Counsel and Secretary	PPurchase	+15K sh	$0.60	+$9,000	22,184
2024-03-07	LCTXLineage Cell Therapeutics, Inc. · Employee Stock Option (Right to Buy)A Award	General Counsel and Secretary	AAward	+650K sh	—	—	650,000
2024-02-11	LCTXLineage Cell Therapeutics, Inc.M Exercise/Conversion	General Counsel and Secretary	MExercise/Conversion	+6,076 sh	—	—	9,674
2024-02-11	LCTXLineage Cell Therapeutics, Inc.F Tax Payment	General Counsel and Secretary	FTax Payment	−2,490 sh	$1.08	−$2,689.2	7,184
2024-02-11	LCTXLineage Cell Therapeutics, Inc. · Restricted Stock UnitsM Exercise/Conversion	General Counsel and Secretary	MExercise/Conversion	−6,076 sh	—	—	12,151
2023-03-09	LCTXLineage Cell Therapeutics, Inc. · Employee Stock Option (Right to Buy)A Award	General Counsel and Secretary	AAward	+650K sh	—	—	650,000
2023-02-11	LCTXLineage Cell Therapeutics, Inc.M Exercise/Conversion	General Counsel and Secretary	MExercise/Conversion	+6,076 sh	—	—	6,076
2023-02-11	LCTXLineage Cell Therapeutics, Inc.F Tax Payment	General Counsel and Secretary	FTax Payment	−2,478 sh	$1.35	−$3,345.3	3,598
2023-02-11	LCTXLineage Cell Therapeutics, Inc. · Restricted Stock UnitsM Exercise/Conversion	General Counsel and Secretary	MExercise/Conversion	−6,076 sh	—	—	18,227
2022-03-10	LCTXLineage Cell Therapeutics, Inc. · Employee Stock Option (Right to Buy)A Award	General Counsel and Secretary	AAward	+650K sh	—	—	650,000
2022-02-11	LCTXLineage Cell Therapeutics, Inc. · Restricted Stock UnitsA Award	General Counsel and Secretary	AAward	+24.3K sh	—	—	24,303
2021-09-01	LCTXLineage Cell Therapeutics, Inc. · Employee Stock Option (right to buy)A Award	General Counsel and Secretary	AAward	+695K sh	—	—	695,000

Recent filings

Accepted (ET)
Mar 64
Samuel George A. III0001193125-26-097181
SEC(opens sec.gov)
Feb 134
Samuel George A. III0001193125-26-052020
SEC(opens sec.gov)
Dec 194
Samuel George A. III0001193125-25-327279
SEC(opens sec.gov)
Mar 124
Samuel George A. III0000950170-25-038113
SEC(opens sec.gov)
Feb 124
Samuel George A. III0000950170-25-018897
SEC(opens sec.gov)
Nov 264
Samuel George A. III0000950170-24-131093
SEC(opens sec.gov)
Mar 84
Samuel George A. III0001493152-24-009384
SEC(opens sec.gov)
Feb 124
Samuel George A. III0001493152-24-005944
SEC(opens sec.gov)
Mar 104
Samuel George A. III0001493152-23-007308
SEC(opens sec.gov)
Feb 144
Samuel George A. III0001493152-23-004899
SEC(opens sec.gov)
Mar 114
Samuel George A. III0001493152-22-006698
SEC(opens sec.gov)

Companies

Lineage Cell Therapeutics, Inc.General Counsel and SecretaryLCTX

Address

C/O LINEAGE CELL THERAPEUTICS 2173 SALK AVENUE, SUITE 200

CARLSBAD, CA, 92008